Mari Spitale - Academia.edu (original) (raw)

Mari Spitale

Uploads

Papers by Mari Spitale

Research paper thumbnail of Clicks away from reduced healthcare expenditures: leveraging the electronic health record to reinforce education efforts

BMJ health & care informatics, Dec 1, 2022

Research paper thumbnail of Clicks away from reduced healthcare expenditures: leveraging the electronic health record to reinforce education efforts

BMJ Health & Care Informatics Online

ObjectivesLupron 11.25 mg has both a narrow indication and a high cost compared to other Lupron p... more ObjectivesLupron 11.25 mg has both a narrow indication and a high cost compared to other Lupron presentations. Prior to our study initiation there was no clear distinction between presentations when ordering within the health-system’s Electronic Health Record (EHR). This resulted in inappropriate product selection, payment and billing errors that negatively impact our healthcare system. To reinforce prior education efforts, a new approach was considered leveraging the EHR with information to steer prescribers to the proper Lupron presentation based on indication. This study aimed to reduce off-label prescribing for Lupron 11.25 mg (NDC 00074-3663-03) by 25% by 02/28/2022 without negatively impacting the insurance collection rate.MethodsBaseline Lupron 11.25 mg adult kit administrations one year prior to intervention and off-label prescribing was found to account for 22.7% of administrations. In December 2021 intervention order questions were added to Lupron 11.25 mg in the EHR. One ...

Research paper thumbnail of Clicks away from reduced healthcare expenditures: leveraging the electronic health record to reinforce education efforts

BMJ health & care informatics, Dec 1, 2022

Research paper thumbnail of Clicks away from reduced healthcare expenditures: leveraging the electronic health record to reinforce education efforts

BMJ Health & Care Informatics Online

ObjectivesLupron 11.25 mg has both a narrow indication and a high cost compared to other Lupron p... more ObjectivesLupron 11.25 mg has both a narrow indication and a high cost compared to other Lupron presentations. Prior to our study initiation there was no clear distinction between presentations when ordering within the health-system’s Electronic Health Record (EHR). This resulted in inappropriate product selection, payment and billing errors that negatively impact our healthcare system. To reinforce prior education efforts, a new approach was considered leveraging the EHR with information to steer prescribers to the proper Lupron presentation based on indication. This study aimed to reduce off-label prescribing for Lupron 11.25 mg (NDC 00074-3663-03) by 25% by 02/28/2022 without negatively impacting the insurance collection rate.MethodsBaseline Lupron 11.25 mg adult kit administrations one year prior to intervention and off-label prescribing was found to account for 22.7% of administrations. In December 2021 intervention order questions were added to Lupron 11.25 mg in the EHR. One ...

Log In